Pacira urges vote for board slate as activist DOMA seeks director seats at June 9 annual meeting

Pacira Biosciences, Inc.

Pacira Biosciences, Inc.

PCRX

0.00
  • Pacira faces a shareholder fight at its June 9 annual meeting as activist DOMA seeks three board seats.
  • Pacira urges holders to back its blue card for Christopher Christie, Samit Hirawat, Thomas Wiggans.
  • ISS, Glass Lewis, Egan-Jones recommend voting for Pacira’s slate, voting against DOMA nominees.
  • Pacira warns a DOMA win could disrupt strategy, curb innovation investment, trigger a potential fire sale.
  • Campaign comes as Pacira highlights 2025 record revenue of USD 726.41 million, 2026 Q1 EXPAREL sales up 5%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606041620PR_NEWS_USPR_____SF76606) on June 04, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.